These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9918425

  • 1. Sulindac inhibits colorectal tumour growth, but not prostaglandin synthesis in the rat.
    Charalambous D, Skinner SA, O'Brien PE.
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1195-200. PubMed ID: 9918425
    [Abstract] [Full Text] [Related]

  • 2. R-flurbiprofen suppresses distal nonmucin-producing colorectal tumors in azoxymethane-treated rats, without suppressing eicosanoid production.
    Martin JE, Le Leu RK, Hu Y, Young GP.
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G860-4. PubMed ID: 20338924
    [Abstract] [Full Text] [Related]

  • 3. Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model.
    Martin JE, Young GP, LE Leu RK, Hu Y.
    Anticancer Res; 2013 Sep; 33(9):3581-8. PubMed ID: 24023283
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of apoptosis by sulindac and piroxicam.
    Waddell WR.
    Clin Sci (Lond); 1998 Sep; 95(3):385-8. PubMed ID: 9730860
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of colon cancer precursors in the rat by sulindac sulphone is not dependent on inhibition of prostaglandin synthesis.
    Charalambous D, O'Brien PE.
    J Gastroenterol Hepatol; 1996 Apr; 11(4):307-10. PubMed ID: 8713695
    [Abstract] [Full Text] [Related]

  • 6. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle.
    Brooks G, Yu XM, Wang Y, Crabbe MJ, Shattock MJ, Harper JV.
    J Pharm Pharmacol; 2003 Apr; 55(4):519-26. PubMed ID: 12803774
    [Abstract] [Full Text] [Related]

  • 7. [Inhibition of vascular smooth muscle cell proliferation by non-steroidal anti-inflammatory drugs].
    Wang YQ, Brooks G, Harper J, Li YQ, Zhu CB, Yuan WZ, Wu XS.
    Shi Yan Sheng Wu Xue Bao; 2003 Apr; 36(2):85-90. PubMed ID: 12858504
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of sulindac on colonic tumour formation in dimethylhydrazine-treated mice.
    Moorghen M, Ince P, Finney KJ, Sunter JP, Watson AJ, Appleton DR.
    Acta Histochem Suppl; 1990 Jun; 39():195-9. PubMed ID: 2080261
    [Abstract] [Full Text] [Related]

  • 12. Sulindac and its derivatives: a novel class of anticancer agents.
    Haanen C.
    Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The influence of zymosan and indomethacin on liver and kidney tumor growth. An experimental study in rats.
    Ohman MG, Blind PJ, Holmberg SB, Naredi PL, Lindnér PG, Hafström LR.
    J Exp Clin Cancer Res; 1997 Sep; 16(3):243-7. PubMed ID: 9387896
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.